cancer profiling, diagnostics
new antibiotics class
Optimum is an international strategic healthcare communications firm, specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. We are experienced and trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, biotech, digital health and healthcare services, large and small.
Watch our Member Showcase Video https://bit.ly/3FFKIIz
Watch our Member Showcase Video https://bit.ly/3FFKIIz
No data available
Our Biosciences Team has advised on a wide variety of matters including research and development agreements, patent and know how licences and assignments, manufacturing agreements, bioinformatics, regulatory matters, clinical trials, patent litigation and competition law. The members of the Biosciences Team pride themselves on their responsive, hands-on and pro-active approach. This includes helping to find venture capital finance for clients through the firm's extensive corporate finance network and advising on intellectual property protection and exploitation. Osborne Clarke recognises that biotechnology companies want to deal with a team of specialists whose experience ensures technically accurate and commercial, pragmatic advice.. . Biotechnology agreements, collaborations, research and devleopment agreements, venture capital and other funding arrangements for biotechnology companies. Represented in most major European jurisdictions and in Silicon Valley.. . Bioinformatics, law, European law, research, colllaboration, contract research, intellectual property, patents, financing, competition law, technology transfer, mergers and acquisitions, due diligence, regulatory matters.
No data available
Sustainable bio-based materials for fashion
PAREXEL is a leading global bio/pharmaceutical services organisation that helps clients expedite time-to-market through our development and launch services. With a full scope of services from first-in-man through proof of concept, PAREXEL Early Phase has a global network of clinical units that test compounds and devices in healthy volunteers and patients, helping our biopharmaceutical clients make valuable decisions quickly and safely. For more information, visit us at https://www.parexel.com/earlyphase
Paspigioni is a full-service contract research organization that supports pharmaceutical and biotechnology companies in conducting interventional and non-interventional clinical trials across phases I—IV.
Our award-winning life sciences team is led by highly-ranked lawyers who advise companies in the biotech, pharmaceutical, diagnostics, veterinary and healthcare sectors. We add value with lawyers who understand the science from their degree subjects, and understand your business, having worked in-house for life science companies, or with them for many years. We act for companies, at all stages of their life cycle, including global pharmaceutical companies, larger plcs and SMEs, together with research organisations, venture capital funds and universities. 'Impressive IP practice acting for life sciences businesses, universities and their spinoffs… Recommended for licence and research agreements.' - Chambers 2017.